Physsec Alcohol Tobacco And Cannabis

---
name: physsec-alcohol-tobacco-and-cannabis
description: "Use when alcohol, tobacco and nicotine, or cannabis intersect with medicine, self-defense or firearms — mechanisms, the evidence-graded legitimate medical uses (Epidiolex, dronabinol and nabilone; ethanol as antiseptic, antidote and procedural drug; nicotine replacement, varenicline, bupropion and cytisinicline), the harms, the December 2025 JAMA cannabis review, the April 2026 Schedule III order and the hemp THC cap, South Carolina's status, § 922(g)(3) after United States v. Hemani, the J-curve and the Surgeon General's alcohol and cancer advisory against the 2025–2030 Dietary Guidelines, nicotine-pouch authorizations and modified-risk orders, why intoxication and weapons do not mix medically, tactically or legally, and the self-medication problem. No dosing or regimens. Skill 6 of 8 of the Physical Security, Self-Defense, Firearms and the ATF Substances reference."
---

# Alcohol, Tobacco and Cannabis: Medicine and Self-Defense

> **Skill 6 of 8** of the *Physical Security, Self-Defense, Firearms, and the "ATF Substances"* reference
> (plugin `physical-security-self-defense-and-firearms`), carrying source Part VI, *Alcohol, Tobacco, Cannabis: Medicine and Self-Defense*: §19–§23 — cannabis, alcohol and tobacco/nicotine on mechanism, medicine, harms, law and self-defense. Sibling skills:
> `physsec-foundations-and-threat-modeling` (§0–§4 — how to read the reference, threat modeling, the security mindset, layered defense and CPTED),
> `physsec-securing-buildings` (§5–§8 — homes, home hardening, organizations and commercial buildings, and targeted violence),
> `physsec-personal-security-and-self-defense` (§9–§13 — personal security, the self-defense hierarchy, training evidence, less-lethal tools and Stop the Bleed),
> `physsec-firearms-mechanics-safety-and-carry` (§14–§16 — how firearms work (conceptual), safety, storage and the risk ledger, choosing, training and carrying),
> `physsec-firearms-and-self-defense-law` (§17–§18 — federal firearms law and South Carolina carry and self-defense law, as of September 2026),
> `physsec-decision-tools-and-contested-questions` (§24–§26 and Part VIII — the personal security plan, spending priorities, the organizational checklist and the contested questions),
> `physsec-reference` (§27–§30 — training and references, the glossary, the currency notes and the sources).
>
> Section numbers are **the source's own and shared across the whole set**: a reference written
> as §N → `skill` points into that sibling skill.

> **Read this first — the source's own limits and tags** (in full at §0 →
> `physsec-foundations-and-threat-modeling`). **Not legal advice** (self-defense law is
> fact-specific and South Carolina case law is detailed — talk to a criminal-defense attorney
> before you need one). **Not medical advice** (no dosing, no regimens). **Not a substitute for
> hands-on training** — firearms handling, medical skills and physical self-defense cannot be
> learned from text. Evidence tags: **\[STRONG\]** replicated, large-sample, or randomized
> evidence; professional consensus · **\[MODERATE\]** consistent observational evidence;
> plausible mechanism · **\[WEAK\]** self-report surveys, small or industry-funded studies,
> expert opinion · **\[CONTESTED\]** serious researchers disagree; both positions presented ·
> **\[LAW-2026\]** legal state as of Sept 2026; verify before relying on it. The source was
> compiled on September 30, 2026 and has not been re-checked for this pack; what will go stale
> first is listed at §29 → `physsec-reference`.

> **If anyone in the household is in crisis**, the source's own list (§27 → `physsec-reference`):
> the **988** Suicide & Crisis Lifeline; the National DV Hotline **1-800-799-7233**; the SAMHSA
> National Helpline **1-800-662-4357**.

> **Pack orientation** (the pack's words, not the source's): Part VI of the source, whole. It analyzes each substance on the same five axes (§19). No
> dosing or regimens are given anywhere in it; where a medical use exists, the source says it
> runs through a clinician.

## §19 The framing

Each substance is analyzed on five axes: **mechanism → legitimate medical uses (evidence-graded) → harms → legal status → intersection with self-defense and firearms.** No dosing or regimens are given; where a medical use exists, it runs through a clinician.

The short version:

|  | Genuine medical role | Self-defense role | Biggest self-defense relevance |
| --- | --- | --- | --- |
| **Alcohol (ethanol)** | Yes — as a disinfectant, an antidote in some settings, and a *procedural* drug; **not** as a beverage | None | Impairment; legal exposure; alcohol is involved in a large share of violence |
| **Tobacco / nicotine** | Nicotine replacement for quitting; no accepted role for tobacco itself | None | Minimal; fire/burn risk; stress self-medication |
| **Cannabis** | Narrow: FDA-approved cannabinoid drugs for specific conditions | None | Federal firearm prohibition (§ 922(g)(3)) — changed substantially in June 2026 |
| **Firearms** | None (medical "role" is on the injury side) | Yes (Part V — §14–§18 → `physsec-firearms-mechanics-safety-and-carry`, `physsec-firearms-and-self-defense-law`) | — |

**\[Pack note: the table's "changed substantially in June 2026" is the source's own one-line
summary. §20 below is the detail, and it stresses that the ruling is narrow — the Court did not
strike § 922(g)(3). Read §20 before relying on the summary.\]**

## §20 Cannabis

**Mechanism.** Plant cannabinoids act on the body's endocannabinoid system. **THC** is a partial agonist at **CB1** receptors (dense in brain regions for memory, coordination, reward and appetite) — the source of intoxication. **CBD** is non-intoxicating, with complex actions at several receptor systems; it is the active drug in the FDA-approved seizure medication.

**Legitimate medical uses — evidence-graded:**

- **FDA-approved products** \[STRONG for labeled indications\]:
  - **Epidiolex** (purified CBD) — seizures in Dravet syndrome, Lennox–Gastaut syndrome, and tuberous sclerosis complex.
  - **Dronabinol** (Marinol, Syndros — synthetic THC) — chemotherapy-induced nausea/vomiting; appetite loss/weight loss in HIV/AIDS.
  - **Nabilone** (Cesamet — synthetic THC analog) — chemotherapy-induced nausea/vomiting.
- **The December 2025 JAMA review** (Hsu et al., >2,500 studies, 2010–2025) found clear support essentially only for those FDA-approved indications; evidence for **chronic pain, anxiety, insomnia and most other common uses was insufficient or inconsistent**. Acute-pain and insomnia RCTs did not support use. Professional societies recommend **against** inhaled cannabis for chronic non-cancer pain and **against** cannabis for any psychiatric disorder. **\[STRONG for the negative/insufficient findings\]**
- An older (2015) JAMA meta-analysis rated evidence for chronic pain and MS spasticity as moderate-quality with modest effects — the newer review is more skeptical, reflecting more and better trials. **\[CONTESTED for chronic pain\]**

**Harms:**

- **Cannabis use disorder**: one meta-analysis cited in the JAMA review found **\~29% of medical-cannabis patients met CUD criteria**.
- **Psychosis/schizophrenia**: risk rises with high-potency THC and adolescent use; in adolescents, high-potency products were associated with markedly higher rates of psychotic symptoms and anxiety disorder.
- **Cannabinoid hyperemesis syndrome** (cyclical severe vomiting in heavy users), cardiovascular events, impaired driving, cognitive effects in youth, drug interactions.
- High-potency (>10% THC) and inhaled products are not recommended for medical use.

**Legal status \[LAW-2026\]:**

- **Federal**: an executive order (Dec 18, 2025) directed rescheduling. On **April 23, 2026** the Justice Department placed **FDA-approved marijuana products and marijuana subject to a qualifying state medical-marijuana license** into **Schedule III**. All other marijuana (including recreational) **remains Schedule I** while DEA completes a broader hearing (held June–July 2026; FDA testified marijuana has an accepted medical use for pain, some anorexia, and chemotherapy nausea). Schedule III is **not** legalization.
- **Hemp**: a federal law caps total THC in consumer hemp products at a trace amount per package starting **November 12, 2026**, which is expected to eliminate most hemp-derived intoxicating products nationally, including in SC. (Verify details.)
- **South Carolina**: cannabis remains **illegal** for recreational and general medical use. The Compassionate Care Act (S.53 in 2025–26) again **died without a floor vote** when the session ended May 14, 2026. SC's narrow low-THC CBD law for certain seizure patients (2014) remains. Because SC has no state medical program, **no SC resident's cannabis falls within the new Schedule III category**.

**Firearms intersection — the big 2026 change:** **\[Pack note: this block is the legal state as of September 2026, as §17's LAW-2026 tag marks the same ruling there; the source does not repeat the tag here — verify before relying on it.\]**

- 18 U.S.C. § 922(g)(3) bans gun possession by any "unlawful user of or addicted to any controlled substance," and marijuana is federally controlled regardless of state law.
- ***United States v. Hemani* (June 18, 2026), opinion by Justice Gorsuch, reportedly unanimous:** prosecuting a man who used marijuana "about every other day" and kept a gun at home, **with no showing that his use made him dangerous**, violated the Second Amendment *as applied*. The government's analogy to founding-era "habitual drunkard" laws failed.
- **The ruling is narrow.** The Court did **not** strike § 922(g)(3); did not address the "addicted to" prong; allowed that the government could still prosecute with an **individualized showing of dangerousness**; and invited Congress to legislate. **Form 4473 still asks the question, and answering falsely is its own felony.** State legality does not override federal law.
- **Unsettled**: whether a *state-licensed* medical user (now in Schedule III) is an "unlawful user" given Schedule III drugs normally require a prescription, which a state card is not. Nobody should rely on this without counsel.
- **Practical**: never handle or carry firearms while impaired by cannabis. Intoxication undermines the "reasonable person" standard in any self-defense claim and invites prosecution under other laws.

## §21 Alcohol (ethanol)

**Mechanism.** Ethanol enhances GABA-A (inhibitory) signaling and blocks NMDA (excitatory) glutamate receptors → sedation, disinhibition, impaired coordination, slowed reaction time, impaired judgment and memory; tolerance and dependence develop with regular use; withdrawal can be dangerous (seizures, delirium tremens) and needs medical management.

**Legitimate medical uses — of ethanol, not of drinking:** \[STRONG\]

- **Antiseptic/disinfectant**: 60–90% alcohol solutions are standard skin and surface disinfectants and hand sanitizers.
- **Antidote**: ethanol blocks alcohol dehydrogenase and was the classic treatment for **methanol and ethylene glycol poisoning**; **fomepizole** has largely replaced it, but ethanol remains a fallback where fomepizole is unavailable.
- **Procedural drug**: dehydrated alcohol is injected in **alcohol septal ablation** for hypertrophic obstructive cardiomyopathy (FDA-approved product), and used for nerve blocks/neurolysis in severe pain and for certain vascular and tumor ablations.
- **Ethanol lock therapy** helps prevent catheter infections in some patients.

**Drinking as medicine — the evidence moved:**

- The old "J-curve" (moderate drinkers appearing healthier than abstainers) is now widely attributed to confounding — including "sick quitters" in the abstainer group. **\[MODERATE–STRONG\]**
- **Cancer**: the January 2025 Surgeon General's Advisory called alcohol a **leading preventable cause of cancer** in the US — about **100,000 cases and 20,000 deaths per year** — causally linked to at least seven cancers (mouth, throat, larynx, esophagus, liver, breast, colorectal), with **no threshold of zero risk**. For women drinking one drink a day, lifetime breast cancer risk rises from roughly 11 in 100 to 13 in 100. **\[STRONG\]**
- **Policy shift**: the **2025–2030 Dietary Guidelines (released January 7, 2026)** dropped the long-standing numeric limits (≤2 drinks/day men, ≤1 women) and the cancer warning, replacing them with "consume less alcohol for better overall health." Medical societies (e.g., AASLD) criticized the change. The **science didn't change; the guidance did.**
- Treatments for alcohol use disorder exist and are underused: **naltrexone, acamprosate, disulfiram**, plus behavioral therapy and mutual-help groups.

**Self-defense intersection:** \[STRONG\]

- **Alcohol is heavily involved in violence** — for both offenders and victims — and is a leading risk factor for sexual assault (the EAAA program in §11 → `physsec-personal-security-and-self-defense` explicitly addresses it).
- It degrades every defensive capacity: awareness, threat recognition, reaction time, fine motor control, judgment about force, and memory afterward.
- **Legally**: voluntary intoxication is generally **not a defense** and can make your perception look unreasonable; SC's alcohol-premises rule forbids **drinking while carrying** in establishments (§18 → `physsec-firearms-and-self-defense-law`); handling firearms drunk can support reckless-conduct charges and destroys credibility in any self-defense claim. **\[Pack note: a legal statement as of September 2026 that the source does not tag LAW-2026 — verify before relying on it.\]**
- Note the legal asymmetry: alcohol isn't a "controlled substance," so § 922(g)(3) doesn't cover drinkers — which is exactly why the government in *Hemani* tried to analogize to historical "habitual drunkard" laws.
- **"Liquid courage"** (drinking to manage fear or social anxiety) reliably backfires: it raises conflict risk while lowering the capacity to handle conflict.

## §22 Tobacco and nicotine

**Mechanism.** Nicotine is an agonist at **nicotinic acetylcholine receptors**; it triggers dopamine release in reward pathways (very high dependence liability, especially via fast-delivery routes like smoking), and raises heart rate and blood pressure. **Smoke** — not nicotine — carries most of the cancer and lung-disease burden (tar, carbon monoxide, carcinogens).

**Harms:** cigarette smoking remains the **leading cause of preventable death** in the US — close to half a million deaths per year. **\[STRONG\]**

**Legitimate medical uses:**

- **Tobacco itself**: none accepted today. (Historical "medicinal" tobacco — including 18th-century tobacco-smoke enemas for drowning victims — is a curiosity, not a practice.)
- **Nicotine replacement therapy (NRT)** — patch, gum, lozenge, inhaler, nasal spray — to help people quit smoking. **\[STRONG\]**
- **Other cessation drugs**: **varenicline** (the most effective single agent) and **bupropion**. **Cytisinicline** (a plant-derived partial agonist long used in Eastern Europe) had an FDA decision date of June 20, 2026; the company disclosed it expected a **Complete Response Letter** (a delay) over third-party manufacturing observations — check current status.
- **Research signals** \[WEAK/CONTESTED\]: smokers have lower rates of ulcerative colitis and Parkinson's disease, which prompted trials of nicotine as treatment. Transdermal nicotine showed modest benefit for ulcerative colitis in some trials but was poorly tolerated and inferior to standard drugs; the NIC-PD trial found transdermal nicotine did **not** slow early Parkinson's. These are not reasons to use nicotine.

**Harm reduction — the 2025–2026 regulatory shift:**

- The FDA authorized **ZYN nicotine pouches** in January 2025 (20 products), finding them lower in harmful constituents than cigarettes and most smokeless tobacco and a net public-health benefit for adults who **completely switch**. By August 21, 2026, **43 pouch products** were authorized (including 11 ZYN ULTRA products at up to 11 mg).
- On **June 30, 2026**, FDA issued the first-ever **modified-risk (MRTP) orders** for nicotine pouches (the same 20 ZYN products), relying largely on Swedish snus epidemiology as a proxy — long-term pouch-specific data remain limited.
- "Authorized" ≠ "approved" ≠ "safe." For a non-smoker, starting nicotine adds risk; for a smoker, complete switching reduces exposure.
- Federal minimum sale age is **21**. **\[Pack note: legal state as of September 2026, untagged in the source — verify before relying on it.\]**

**Self-defense intersection:** essentially none. (Folklore about throwing snuff in an attacker's eyes is not a serious technique.) Real relevance: nicotine withdrawal worsens irritability and conflict; smoking and vaping are fire/burn and battery-fire hazards; nicotine is sometimes used to self-medicate stress and ADHD symptoms — better-evidenced treatments exist.

## §23 The self-medication problem (all three substances)

A recurring real-world pattern: people use alcohol, nicotine or cannabis to manage **fear, hypervigilance, trauma, anxiety, insomnia, or attention problems** — the same states that make people feel unsafe. The self-medication hypothesis has decent observational support; the outcomes are generally poor: tolerance, dependence, rebound anxiety and sleep disruption, and — in the firearms context — impaired judgment around lethal tools and federal legal exposure. Evidence-based alternatives (trauma-focused therapy, CBT for insomnia, appropriate medications under a clinician) outperform self-medication over time. **\[MODERATE\]**

## Where to go next (pack navigation, not source text)

- **§ 922(g) and South Carolina's alcohol-premises rule in full** — §17–§18 → `physsec-firearms-and-self-defense-law`.
- **The EAAA program** — §11 → `physsec-personal-security-and-self-defense`.
- **Medical cannabis, moderate drinking and nicotine pouches as contested questions** — Part VIII → `physsec-decision-tools-and-contested-questions`.
- **What will go stale first** — §29 → `physsec-reference`.